CNP and myeloid sarcoma: A significantly elevated antibody reactivity was observed, predominantly of the IgM class, against CNPase in a subset of MS patients (52 out of 70)—a finding absent in HC and patients with systemic lupus erythematosus (SLE), and present only in a minority of patients with OND [76].